Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage

MLA

A. Polachek, et al. “Soluble ST2 and CXCL-10 May Serve as Biomarkers of Subclinical Diastolic Dysfunction in SLE and Correlate with Disease Activity and Damage.” Lupus, vol. 29, no. 11, Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e7ce84e1223f4e076d274ef8f58c0998&authtype=sso&custid=ns315887.

APA

A. Polachek, Ori Elkayam, Daphna Paran, Yan Topilsky, Smadar Gertel, Sara Borok, Sevan Letourneau-Shesaf, Ehud Chorin, Ofir Elaluof, Ilana Kaufman, Dan Caspi, Irena Wigler, Shlomo Berliner, Michal Laufer-Perl, Uri Arad, Jonathan Wollman, David Levartovsky, Eihab Ghantous, Aviram Hochstadt, … Valerie Aloush. (2020). Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage. Lupus, 29(11).

Chicago

A. Polachek, Ori Elkayam, Daphna Paran, Yan Topilsky, Smadar Gertel, Sara Borok, Sevan Letourneau-Shesaf, et al. 2020. “Soluble ST2 and CXCL-10 May Serve as Biomarkers of Subclinical Diastolic Dysfunction in SLE and Correlate with Disease Activity and Damage.” Lupus 29 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e7ce84e1223f4e076d274ef8f58c0998&authtype=sso&custid=ns315887.